Delsam Pharma

Delsam Pharma is a privately held New York-based over-the-counter pharmaceutical company that markets private-label, brand-equivalent consumer medications, with a visible focus on ophthalmic products. Publicly available information indicates the company has sold products including Artificial Tears and Artificial Eye Ointment for relief of dry and irritated eyes. FDA materials describe Delsam Pharma LLC as operating as a distributor of these ophthalmic drug products, which were manufactured by contract manufacturer Global Pharma Healthcare Private Limited. The company became widely known following the 2023 recalls of certain Delsam-branded eye products linked to contamination concerns and subsequent FDA enforcement activity. Based on its website, Delsam continues to present itself as an active family-owned OTC medication company serving U.S. consumers.